Format
Sort by

Send to:

Choose Destination

Results: 4

1.

Immunogenicity and safety of 13-valent pneumococcal conjugate vaccine in children previously immunized with 7-valent pneumococcal conjugate vaccine.

Frenck R Jr, Thompson A, Yeh SH, London A, Sidhu MS, Patterson S, Gruber WC, Emini EA, Scott DA, Gurtman A; 3011 Study Group.

Pediatr Infect Dis J. 2011 Dec;30(12):1086-91. doi: 10.1097/INF.0b013e3182372c6a.

PMID:
21983216
[PubMed - indexed for MEDLINE]
2.

Immunogenicity and safety of 13-valent pneumococcal conjugate vaccine in infants and toddlers.

Yeh SH, Gurtman A, Hurley DC, Block SL, Schwartz RH, Patterson S, Jansen KU, Love J, Gruber WC, Emini EA, Scott DA; 004 Study Group.

Pediatrics. 2010 Sep;126(3):e493-505. doi: 10.1542/peds.2009-3027. Epub 2010 Aug 23.

PMID:
20732948
[PubMed - indexed for MEDLINE]
Free Article
3.

Safety and immunogenicity of a 13-valent pneumococcal conjugate vaccine.

Bryant KA, Block SL, Baker SA, Gruber WC, Scott DA; PCV13 Infant Study Group.

Pediatrics. 2010 May;125(5):866-75. doi: 10.1542/peds.2009-1405.

PMID:
20435707
[PubMed - indexed for MEDLINE]
Free Article
4.

Growth and tolerance studies of a new infant formula.

Sickles VS, Tuley RJ, Bader P, Carnaggio VA, Exon WJ, Hargett IR, Keathley SE, Wolf R, Cordano A.

Clin Pediatr (Phila). 1984 Nov;23(11):617-22.

PMID:
6488661
[PubMed - indexed for MEDLINE]
Format
Sort by

Send to:

Choose Destination

Supplemental Content

Loading ...
Write to the Help Desk